Skip to content

Methods of Weight Loss in Overweight Coronary Patients

Methods of Weight Loss in Overweight Coronary Patients

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00628277
Enrollment
74
Registered
2008-03-05
Start date
2002-10-31
Completion date
2007-07-31
Last updated
2008-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, coronary heart disease, coronary risk factors, weight loss, exercise

Brief summary

We hypothesize that a combination of high-caloric expenditure exercise and behavioral weight loss counseling would lead to a greater loss of fat mass and a greater improvement in cardiometabolic risk factors that standard (lower caloric expenditure) cardiac rehabilitation exercise plus counseling.

Detailed description

We hypothesize that a combination of high-caloric expenditure exercise and behavioral weight loss counseling would lead to a greater loss of fat mass and a greater improvement in cardiometabolic risk factors that standard (lower caloric expenditure) cardiac rehabilitation exercise plus counseling. The study population consists of overweight (BMI \>27) patients with established coronary heart disease. The exercise and counseling program was of 4 months duration with extended follow up at 1 year.

Interventions

BEHAVIORALhigh caloric expenditure exercise

high caloric expenditure exercise plus dietary counseling

BEHAVIORALlow caloric expenditure exercise plus dietary counseling

low caloric expenditure exercise plus dietary counseling

Sponsors

University of Vermont
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Coronary heart disease * BMI \> 27 * Peak Vo2 \> 14.4 ml/kg/min

Exclusion criteria

* Presence of diabetes

Design outcomes

Primary

MeasureTime frame
Fat Mass4 months, 12 months

Secondary

MeasureTime frame
Intrabdominal (visceral) fat4 months
Insulin stimulated glucose disposal4 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026